From September 3-7, 2012, MAPS Lead Clinical Research Associate Berra Yazar-Klosinski, Ph.D., visited the study site for our completed Swiss study of LSD-assisted psychotherapy for anxiety associated with advanced-stage illness for the final closeout meeting with Principal Investigator Peter Gasser, M.D. During the visit, the researchers collected study case report forms, ensured that data accountability procedures were in place, and the data files were complete and ready to be stored. The team also made progress preparing the results for publication.
